Xu X - Search Results

1

Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation.

Liu R, Peng K, Yu Y, Liang L, Xu X, Li W, Yu S, Liu T. Liu R, et al. Among authors: xu x. Biomed Res Int. 2018 Jan 31;2018:5920608. doi: 10.1155/2018/5920608. eCollection 2018. Biomed Res Int. 2018. PMID: 29662888 Free PMC article.

2

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways.

Cui Y, Wang Y, Li H, Li Q, Yu Y, Xu X, Xu B, Liu T. Cui Y, et al. Among authors: xu b, xu x. Oncotarget. 2016 Jun 7;7(23):34356-70. doi: 10.18632/oncotarget.8879. Oncotarget. 2016. PMID: 27102302 Free PMC article.

3

FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc.

Yu Y, Guo M, Wei Y, Yu S, Li H, Wang Y, Xu X, Cui Y, Tian J, Liang L, Peng K, Liu T. Yu Y, et al. Among authors: xu x. Oncotarget. 2016 Dec 6;7(49):80888-80900. doi: 10.18632/oncotarget.13105. Oncotarget. 2016. PMID: 27825133 Free PMC article.

4

Identification and validation of cetuximab resistance associated long noncoding RNA biomarkers in metastatic colorectal cancer.

Peng K, Liu R, Yu Y, Liang L, Yu S, Xu X, Liu T. Peng K, et al. Among authors: xu x. Biomed Pharmacother. 2018 Jan;97:1138-1146. doi: 10.1016/j.biopha.2017.11.031. Epub 2017 Nov 10. Biomed Pharmacother. 2018. PMID: 29136952

5

Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.

Chen E, Qin X, Peng K, Xu X, Li W, Cheng X, Tang C, Cui Y, Wang Z, Liu T. Chen E, et al. Among authors: xu x. Cell Physiol Biochem. 2018;45(5):1731-1746. doi: 10.1159/000487782. Epub 2018 Feb 23. Cell Physiol Biochem. 2018. PMID: 29495008 Free article.

6

SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.

Yu Y, Peng K, Li H, Zhuang R, Wang Y, Li W, Yu S, Liang L, Xu X, Liu T. Yu Y, et al. Among authors: xu x. Oncol Rep. 2018 May;39(5):2235-2242. doi: 10.3892/or.2018.6323. Epub 2018 Mar 19. Oncol Rep. 2018. PMID: 29565456

7

A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis.

Tang C, Yu S, Jiang H, Li W, Xu X, Cheng X, Peng K, Chen E, Cui Y, Liu T. Tang C, et al. Among authors: xu x. J Cancer. 2018 Feb 28;9(6):1057-1066. doi: 10.7150/jca.23391. eCollection 2018. J Cancer. 2018. PMID: 29581785 Free PMC article.

8

Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries.

Chen E, Xu X, Liu T. Chen E, et al. Among authors: xu x. J Oncol. 2018 Apr 23;2018:3979135. doi: 10.1155/2018/3979135. eCollection 2018. J Oncol. 2018. PMID: 29849630 Free PMC article. Review.

9

Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.

Chen E, Xu X, Liu R, Liu T. Chen E, et al. Among authors: xu x. Biomed Res Int. 2018 May 22;2018:6784607. doi: 10.1155/2018/6784607. eCollection 2018. Biomed Res Int. 2018. PMID: 29951542 Free PMC article. Review.

10

An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.

Liang L, Tian J, Yu Y, Wang Z, Peng K, Liu R, Wang Y, Xu X, Li H, Zhuang R, Cui Y, Zhu C, Liu T. Liang L, et al. Among authors: xu x. Cell Physiol Biochem. 2018;50(2):768-782. doi: 10.1159/000494242. Epub 2018 Oct 11. Cell Physiol Biochem. 2018. PMID: 30308491 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,380 results

Search Page

Filters